期刊文献+

干扰素α2a与白细胞介素-2联合作用对体外HepG2.2.15细胞增殖及乙型肝炎病毒复制的影响 被引量:4

Effect of interferon α2a combined with interleukin-2 on proliferation of HepG2.2.15 cells and replication of hepatitis B virus in vitro
原文传递
导出
摘要 目的探讨干扰素α2a(interferonα2a,IFNα2a)与白细胞介素-2(interleukin-2,IL-2)联合作用对体外肝癌细胞HepG2.2.15增殖及乙型肝炎病毒(hepatitis B virus,HBV)复制的影响。方法用不同浓度的IFNα2a(5 000、10 000、15 000 IU/ml)和IL-2(2 500、5 000、10 000 IU/ml)单独及联合作用HepG2.2.15细胞96 h后,采用WST-1法检测细胞增殖情况,倒置相差显微镜观察联合作用组细胞形态学变化,ELISA法检测联合作用组细胞上清中HBsAg和HBeAg的表达,斑点杂交法检测联合作用组细胞HBV-DNA的复制情况。结果与不同浓度的IFNα2a和IL-2单独作用相比,二者联合作用对HepG2.2.15细胞增殖的抑制作用明显增强(P<0.05);IFNα2a与IL-2联合作用组HepG2.2.15细胞显微镜下可见细胞逐渐变圆,胞浆中颗粒增多,增殖变慢,细胞间接触不紧密,细胞周围碎片增多;联合作用组细胞培养上清中HBsAg和HBeAg的表达明显受到抑制(P<0.05);5 000 IU/ml IFNα2a+10 000 IU/ml IL-2、10 000 IU/ml IFNα2a+10 000 IU/ml IL-2和15 000 IU/ml IFNα2a+10 000 IU/ml IL-2对HepG2.2.15细胞HBV-DNA的复制有抑制作用。结论 IFNα2a与IL-2联合作用对HepG 2.2.15细胞增殖及HBV-DNA复制均有抑制作用。本实验为后续体内动物实验及筛选合适的疫苗佐剂奠定了基础,也为新型乙型肝炎疫苗及治疗性乙型肝炎疫苗的研究提供了参考。 Objective To investigate the effect of interferon α2a(IFNα2a) combined with interleukin-2(IL-2) on proliferation of HepG2.2.15 cells and replication of hepatitis B virus(HBV) in vitro.Methods HepG2.2.15 cells were treated with various concentrations of IFNα2a(5 000,10 000 and 15 000 IU / ml) and IL-2(2 500,5 000 and 10 000 IU / ml) alone and in combination for 96 h respectively,the determined for proliferation by WST-1 method.The morphology of cells treated with IFNα2a in combination with IL-2 was observed by inverted phase contrast microscopy,while the expressions of HBsAg and HBeAg in supernatant by ELISA,and the replication of HBV DNA by dot blot.Results The treatment with various concentrations of IFNα2a in combination with IL-2 showed enhanced inhibitory effect on proliferation of HepG2.2.15 cells as compared with that with IFNα2a or IL-2 alone(P 0.05).The cells treated with IFNα2a combined with IL-2 became round gradually under microscope,while the particles increased in the cytoplasm.The cells grew slowly,between which the contact was loose,and around which the pieces increased.The expressions of HBsAg and HBeAg in the culture supernatant of HepG22.2.15 cells treated with IFNα2a combined with IL-2 were inhibited significantly(P 0.05).However,5 000 IU / ml IFNα2a + 10 000 IU / ml IL-2,10 000 IU / ml IFNα2a + 10 000 IU / ml IL-2 and 15 000 IU / ml IFNα2a + 10 000 IU / ml IL-2 showed inhibitory effect on replication of HBV-DNA in HepG2.2.15 cells.Conclusion IFNα2a combined with IL-2 inhibited both the proliferation of HepG2.2.15 cells and the replication of HBV in vitro,which laid a foundation of further animal experiments in vivo and screening of appropriate vaccine adjuvant,and provided a reference for study on novel and therapeutic hepatitis B vaccines.
出处 《中国生物制品学杂志》 CAS CSCD 2013年第7期969-973,共5页 Chinese Journal of Biologicals
关键词 干扰素Α2A 白细胞介素-2 肝癌细胞 细胞增殖 病毒复制 Interferon α2a(IFNα2a) Interleukin-2(IL-2) Liver cancer cells Cell proliferation Virus replication
  • 相关文献

参考文献10

二级参考文献72

共引文献76

同被引文献26

  • 1Stephanos J. Hadziyannis.Update on Hepatitis B Virus Infection:Focus on Treatment[J].Journal of Clinical and Translational Hepatology,2014,2(4):285-291. 被引量:6
  • 2闫杰,谢雯,成军.治疗性乙型肝炎疫苗研究进展[J].中国医学前沿杂志(电子版),2008(2):70-73\r\n. 被引量:1
  • 3邵丽军,刘照惠,金立杰,李利,李猛,谷丽娟,赵晓林,杨屹.HBV PreS2-MBP融合蛋白质粒构建及在大肠杆菌中的表达[J].中国生物制品学杂志,2006,19(3):255-258. 被引量:2
  • 4Hakan Senturk,Fehmi Tabak,Resat Ozaras,Levent Erdem,Billur Canbakan,Ali Mert,Ibrahim Yurdakul.Efficacy of Pre-S-containing HBV Vaccine Combined with Lamivudine in the Treatment of Chronic HBV Infection[J].Digestive Diseases and Sciences.2009(9)
  • 5MEHMETHELVACI,ASLIKIZILGUNESLER,ERHUNKASIRGA,EBRUOZBAL,MUGEKUZU,GULBENSOZEN.Efficacy of hepatitis B vaccination and interferon‐α‐2b combination therapy versus interferon‐α‐2b monotherapy in children with chronic hepatitis B[J].Journal of Gastroenterology and Hepatology.2004(7)
  • 6Janssen HL,van Zonneveld M,Senturk H,et al.Pegylated inter- feron alfa-2b alone or in combination with lamivudine for HbeAg- positive chronic hepatitis B:8 randomised trial[J].Lancet,2005,365(9454):123-129.
  • 7Buster EH,Ter Borg MJ,Janssen HL.Pegylated interferon alpha for chronic hepatitis B-alone or in combination with lamivudine [J].Hot Topics in Viral Hepatitis,2007,4(39):21-28.
  • 8Werle-Lapostorlle B,Bowden S,Locamini,et al.Persistence ofc- ccDNA during the natural history of chronic hepatitis B and decline during ade fovior dipivxil therapy [J].Gastroenterology,2004,126(7):1750.
  • 9Guidotti LG,Chisari FV.Cytokine-mediated control of viral infec- tions[J].Virology,2000,273(2):221-227.
  • 10Zhou T,Guo JT,Nunes FA,et al.Combination therapy with lami- vudine and adenovirus causes transient suppression of chronic woodchuck hepatitis B virus infections [J].J Virol,2000,74(24):11754-11763.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部